Resistance to a drug blocking human immunodeficiency virus type 1 entry (RPR103611) is conferred by mutations in gp41.

A triterpene derived from betulinic acid (RPR103611) blocks human immunodeficiency virus type 1 (HIV-1) infection and fusion of CD4+ cells with cells expressing HIV-1 envelope proteins (gp120 and gp41), suggesting an effect on virus entry. This compound did not block infection by a subtype D HIV-1 s...

Full description

Saved in:
Bibliographic Details
Main Authors: Labrosse, B, Pleskoff, O, Sol, N, Jones, C, Hénin, Y, Alizon, M
Format: Artigo
Language:Inglês
Published: 1997
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC192280/
https://ncbi.nlm.nih.gov/pubmed/9343174
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items